Molecular mechanisms for tumour resistance to chemotherapy
Top Cited Papers
- 4 July 2016
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 43 (8), 723-737
- https://doi.org/10.1111/1440-1681.12581
Abstract
Chemotherapy is one of the prevailing methods used to treat malignant tumours, but the outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually generate resistance to almost all chemotherapeutic drugs via a variety of distinct mechanisms and pathways. Chemotherapeutic resistance, either intrinsic or acquired, is caused and sustained by reduced drug accumulation and increased drug export, alterations in drug targets and signalling transduction molecules, increased repair of drug-induced DNA damage, and evasion of apoptosis. In order to better understand the mechanisms of chemoresistance, this review highlights our current knowledge of the role of altered drug metabolism and transport and deregulation of apoptosis and autophagy in the development of tumour chemoresistance. Reduced intracellular activation of prodrugs (e.g. thiotepa and tegafur) or enhanced drug inactivation by Phase I and II enzymes contributes to the development of chemoresistance. Both primary and acquired resistance can be caused by alterations in the transport of anticancer drugs which is mediated by a variety of drug transporters such as P-glycoprotein (P-gp), multidrug resistance associated proteins, and breast cancer resistance protein. Presently there is a line of evidence indicating that deregulation of programmed cell death including apoptosis and autophagy is also an important mechanism for tumour resistance to anticancer drugs. Reversal of chemoresistance is likely via pharmacological and biological approaches. Further studies are warranted to grasp the full picture of how each type of cancer cells develop resistance to anticancer drugs and to identify novel strategies to overcome it.Keywords
Funding Information
- National Natural Science Foundation of China (20152ACB20019)
This publication has 99 references indexed in Scilit:
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death & Disease, 2013
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistanceDrug Resistance Updates, 2012
- Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL)Archives of Biochemistry and Biophysics, 2011
- Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cellsApoptosis, 2010
- Termination of autophagy and reformation of lysosomes regulated by mTORNature, 2010
- ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapyLife Sciences, 2010
- Autophagy Suppresses Tumorigenesis through Elimination of p62Cell, 2009
- Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced ApoptosisOnline Journal of Public Health Informatics, 2004
- Cell Death: Critical Control PointsCell, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002